Carl Zeiss Meditec AG
CZMWF · OTC
9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | |
|---|---|---|---|---|
| Revenue | $2,614,008 | $2,066,127 | $2,089,300 | $1,902,836 |
| % Growth | 26.5% | -1.1% | 9.8% | – |
| Cost of Goods Sold | $1,234,985 | $977,497 | $883,535 | $775,238 |
| Gross Profit | $1,379,023 | $1,088,630 | $1,205,765 | $1,127,598 |
| % Margin | 52.8% | 52.7% | 57.7% | 59.3% |
| R&D Expenses | $326,275 | $343,089 | $349,278 | $291,365 |
| G&A Expenses | $131,421 | $111,010 | $83,778 | $77,881 |
| SG&A Expenses | $626,519 | $569,208 | $504,057 | $438,060 |
| Sales & Mktg Exp. | $495,098 | $458,198 | $420,279 | $360,179 |
| Other Operating Expenses | $124,886 | $54,982 | $25,294 | $1,294 |
| Operating Expenses | $1,077,680 | $967,279 | $878,629 | $730,719 |
| Operating Income | $301,343 | $121,351 | $327,136 | $396,879 |
| % Margin | 11.5% | 5.9% | 15.7% | 20.9% |
| Other Income/Exp. Net | -$73,822 | $119,515 | $85,428 | $6,610 |
| Pre-Tax Income | $227,521 | $240,866 | $412,564 | $403,489 |
| Tax Expense | $51,547 | $60,712 | $120,555 | $107,578 |
| Net Income | $165,701 | $178,726 | $290,396 | $293,909 |
| % Margin | 6.3% | 8.7% | 13.9% | 15.4% |
| EPS | 1.89 | 2.01 | 3.25 | 3.29 |
| % Growth | -6% | -38.2% | -1.2% | – |
| EPS Diluted | 1.89 | 2.01 | 3.25 | 3.29 |
| Weighted Avg Shares Out | 87,536 | 88,851 | 89,441 | 89,441 |
| Weighted Avg Shares Out Dil | 87,536 | 88,851 | 89,441 | 89,441 |
| Supplemental Information | – | – | – | – |
| Interest Income | $6,570 | $23,273 | $29,047 | $12,985 |
| Interest Expense | $26,624 | $29,424 | $1,916 | $8,917 |
| Depreciation & Amortization | $148,297 | $37,641 | $74,063 | $69,769 |
| EBITDA | $406,996 | $225,051 | $501,877 | $482,851 |
| % Margin | 15.6% | 10.9% | 24% | 25.4% |